IE 11 Not Supported

For optimal browsing, we recommend Chrome, Firefox or Safari browsers.

Do We Need a Delta Variant Booster Shot?

FDA says no, not yet.

Pfizer made news yesterday by announcing that it had developed a version of its RNA vaccine to address the Delta variant that is currently spreading across the United States and increasing hospitalizations — in unvaccinated people.

The company also indicated that it would seek Food and Drug Administration (FDA) approval for this new version of the already very effective vaccine.

The immediate reaction from government authorities was “not so fast!” The current versions of the RNA vaccine from Pfizer and Moderna have been very effective at preventing hospitalizations and deaths, even from the Delta variant.

Pfizer cites preliminary data from Israel as to the effectiveness of the new vaccine appearing to be tailing off a bit after six months.

For now, we’ll need to sit tight and let the scientists duke it out and see what the statistics show. One thing is for sure — of the 9,775 deaths in June here in the U.S., 98.2 percent of them were people who chose not to be vaccinated. That simple math tells me something is still working!
Eric Holdeman is a nationally known emergency manager. He has worked in emergency management at the federal, state and local government levels. Today he serves as the Director, Center for Regional Disaster Resilience (CRDR), which is part of the Pacific Northwest Economic Region (PNWER). The focus for his work there is engaging the public and private sectors to work collaboratively on issues of common interest, regionally and cross jurisdictionally.
Special Projects
Sponsored Articles